Transplantation, Stem Cell: Clinical Trials

3 trials for Transplantation, Stem Cell, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 not yet recruiting, 1 recruiting. 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 23Not yet recruiting 2, Recruiting 1

Follow Transplantation, Stem Cell: new trials by email Literature Review of Transplantation, Stem Cell trials Research Report on Transplantation, Stem Cell

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
SHR2554/AZA + Overlapped mBUCY, mBUCY conditioning Regimen Group - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingThe First Affiliated Hospital of Soochow University1802026-06-012026-06-10
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
SHR2554/AZA + Overlapped TBF, mBUCY conditioning regimen - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 2Not yet recruitingThe First Affiliated Hospital of Soochow University1602026-06-012026-05-01
Study on the Efficacy and Safety of the TmBU Conditioning Regimen in High-risk or Relapsed/Refractory Acute Leukemia
TmBU conditioning Regimen, mBUCY conditioning regimen - Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
Phase 2RecruitingThe First Affiliated Hospital of Soochow University482025-01-302026-04-23

Narrower conditions

Leukemia, Myeloid, Acute (3)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)

Broader conditions

Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Immune System Diseases (3)  ·  Immunoproliferative Disorders (3)  ·  Leukemia (3)  ·  Leukemia, Lymphoid (3)  ·  Leukemia, Myeloid (3)  ·  Lymphatic Diseases (3)  ·  Lymphoproliferative Disorders (3)  ·  Neoplasms (3)  ·  Neoplasms by Histologic Type (3)

Interventions

Control Groups (2)

Sponsors

The First Affiliated Hospital of Soochow University (3)

Countries

China (3)

Top investigators

Sheng-Li Xue, M.D. (1)